World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 3 March 2020
Main ID:  ISRCTN10546597
Date of registration: 14/09/2016
Prospective Registration: No
Primary sponsor: National University of Singapore
Public title: Improving outcomes in patients with diabetes and on dialysis – A brief intervention to support self-care and adjustment
Scientific title: Improving outcomes in patients with coexisting multi-morbid conditions – the development and evaluation of the combined diabetes and renal control feasibility trial (C-DIRECT)
Date of first enrolment: 01/05/2016
Target sample size: 44
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN10546597
Study type:  Interventional
Study design:  Feasibility parallel arm blinded randomised controlled trial (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Singapore
Contacts
Name: Konstadina    Griva
Address:  National University of Singapore Department of Psychology 9 Arts Link 117570 Singapore Singapore
Telephone: +65 (0)65163156
Email: psygk@nus.edu.sg
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Aged 21 years or over
2. Diagnosed with type 1 or type 2 diabetes and End Stage Renal Disease
3. Receive hospital haemodialysis three times for a minimum of 3 months
4. Hb1Ac = >8%.

Exclusion criteria:
1. Suffering from severe mental illness e.g. psychosis
2. Insufficient communication skills in the English, Malay or Chinese language to participate in the intervention
3. Any other severe communication difficulties that would prevent them following study procedures


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Coexisting Diabetes Mellitus and End Stage Renal Disease
Nutritional, Metabolic, Endocrine
Coexisting Diabetes Mellitus and End Stage Renal Disease
Intervention(s)

Participants are randomised to one of two groups in a 1:1 allocation ratio.

Intervention group: Participants will take part in a brief nurse led program designed to support adjustments to the lifestyle changes required by diabetes patients on hemodialysis. This will involve 3 visits by the NKF diabetes link nurses during one of their regular dialysis sessions at the dialysis center. During these sessions, the nurses will support patients in setting goals and will provide education around diet, medication, exercise, foot care or blood sugar monitoring, if they so require (based on Elicit-Provide-Elicit framework in Motivational Interviewing). The contents of the sessions will be tailored to their needs and preferences for support. Participants will decide the direction and content of these empowering conversations. A self-management record sheet will be used as part of the consultation. DM Link renal nurses and patients work together to complete the sheet in each session. Focus of each session, goal setting and confidence will be recorded. These visits will take approximately 30 minutes and will be scheduled over 3 consecutive weeks.

Control group: Participants will receive standard care for the duration of the study.

Assessment procedures are identical for control and intervention participants . These include a baseline assessment (self report questionnaires listed) and follow up assessment (12 weeks post baseline) - this is approximately 2-4 weeks post completion of the C-DIRECT intervention. Follow up assessments include same set of questionnaires (C-DRECT participants will also be invited to participate in a brief interview on their experience of the program).
Primary Outcome(s)

1. HbA1c and home glucose monitoring records
2. Biochemical markers (phosphate & potassium levels)
3. Protein catabolic rate, albumin, hemoglobin
4. Interdialytic weight gains v) blood pressure readings
Secondary Outcome(s)

1. Generic and diabetes specific distress is measured using the Hospital Anxiety and Depression Scale and Problem Areas in Diabetes Scale at baseline and 4 weeks post intervention
2. Health related Quality of Life is measured using the Kidney Disease Quality of Life Short Form at baseline and 2/4 weeks post intervention
3. Self-reported adherence/self-care is measured using the Dialysis Diet and Fluid Non-Adherence Questionnaire, Summary of 2/4. Diabetes Self-Care Activities and self-report adherence items developed for study at baseline and 2-4 weeks post intervention
4. Self-Management Skills are measured using the Self Efficacy Scale and Health Education Impact Questionnaire at baseline and 2/4 weeks post intervention
5. Experiences of the intervention are measured through qualitative interviews with intervention participants 4 weeks post intervention
Secondary ID(s)
N/A
Source(s) of Monetary Support
National Kidney Foundation Singapore
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
National University of Singapore Institutional Review Board, 01/04/2016, ref: 13-394
Results
Results available: Yes
Date Posted:
Date Completed: 31/12/2016
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history